Paid Clinical Trials Baltimore

Discover 2,128 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,128

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Baltimore MD, Washington DC, Frederick MD, Norfolk VAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Baltimore MD, Glen Burnie MD, Columbia MD, Alexandria VAshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Annapolis MD, Newark DE, Little Silver NJ, Norfolk VAshow 34 more

Code:

NCT05552976

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mezigdomide

Carfilzomib

Dexamethasone

DexamethasonePerivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Recruiting

PHASE2

Sponsor:

Mercator MedSystems, Inc.

Location:

Hyattsville MD, Norfolk VA, Darien CT, Stony Brook NYshow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

PembrolizumabLong-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Baltimore MD, Columbia MD, Washington DC, Philadelphia PAshow 68 more

Code:

NCT03486873

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Standard of Care (SOC)

Lenvatinib

Olaparib

MK-4280

NMES & HPROImpact of NMES and HPRO on Recovery After SAH- Pilot Study

Recruiting

Sponsor:

University of Maryland, Baltimore

Location:

Baltimore MD

Code:

NCT03201094

Conditions

Subarachnoid Hemorrhage

Muscle Atrophy

Inflammation

Nutritional and Metabolic Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Neuromuscular Electrical Stimulation (NMES)

High Protein Supplementation

RRx-001RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Recruiting

PHASE2

Sponsor:

EpicentRx, Inc.

Location:

Baltimore MD, Charlottesville VA, Greenville NC, Columbus OHshow 10 more

Code:

NCT05966194

Conditions

Oral Mucositis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RRx-001

Intensity Modulated Radiation Therapy (IMRT)

Cisplatin for injection 100 mg/m2

TivozanibEvaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Recruiting

PHASE1

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda MD

Code:

NCT04645160

Conditions

Cholangiocarcinoma

Bile Duct Neoplasm

Biliary Tract Malignancy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tivozanib

Observational StudyScreening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

Recruiting

Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Location:

Bethesda MD

Code:

NCT06615973

Conditions

Stroke

Brain Disease

Vascular Diseases

Cerebrovascular Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Low Blood SugarDiagnosing and Treating Low Blood Sugar Levels

Recruiting

Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Location:

Bethesda MD

Code:

NCT00001276

Conditions

Hypoglycemia

Insulinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Ferric CitrateStudy to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Recruiting

PHASE3

Sponsor:

Keryx Biopharmaceuticals

Location:

Baltimore MD, Cincinnati OH, Grand Rapids MI, Birmingham ALshow 10 more

Code:

NCT04523727

Conditions

Hyperphosphatemia Related to Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 6 - 16

Healthy Volunteers: Not accepted

Interventions

ferric citrate